Treatment and diagnosis of dementia
US4939124A · kind A · utility
6Cited by
4References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 26, 1988 |
| Grant date | Jul 3, 1990 |
| Priority date | — |
| Expiry date | Jan 26, 2008 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/811
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The administration of Somatostatin and growth hormone releasing factor at useful dosage levels alleviates the symptoms of various neuropsychiatric disorders. Growth hormone and neuropsychiatric responses to the administration of growth hormone releasing factor to mammals indicate its usefulness as an antemortem marker for senile dementia of the Alzheimer's type.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.